

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | C4-dicarboxylate transport (GO:0015740) | 4.87400061 |
| 2 | layer formation in cerebral cortex (GO:0021819) | 4.87003007 |
| 3 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.52076684 |
| 4 | axonal fasciculation (GO:0007413) | 4.48061733 |
| 5 | neuron recognition (GO:0008038) | 4.31369732 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.11042401 |
| 7 | mating behavior (GO:0007617) | 4.09832060 |
| 8 | gamma-aminobutyric acid transport (GO:0015812) | 4.03716424 |
| 9 | axonemal dynein complex assembly (GO:0070286) | 3.99642654 |
| 10 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.96679920 |
| 11 | negative regulation of B cell mediated immunity (GO:0002713) | 3.96679920 |
| 12 | cerebellar granule cell differentiation (GO:0021707) | 3.92109288 |
| 13 | dendritic spine morphogenesis (GO:0060997) | 3.76151292 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.65903657 |
| 15 | response to histamine (GO:0034776) | 3.65191443 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.63602194 |
| 17 | presynaptic membrane organization (GO:0097090) | 3.56066884 |
| 18 | synaptic vesicle maturation (GO:0016188) | 3.54927550 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.51901745 |
| 20 | presynaptic membrane assembly (GO:0097105) | 3.49124084 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48265267 |
| 22 | synaptic vesicle exocytosis (GO:0016079) | 3.41069569 |
| 23 | nucleobase catabolic process (GO:0046113) | 3.38556503 |
| 24 | glutamate secretion (GO:0014047) | 3.36918038 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.33799416 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.32271465 |
| 27 | atrial cardiac muscle cell action potential (GO:0086014) | 3.32165503 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.30937039 |
| 29 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.29275468 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.26107208 |
| 31 | vocalization behavior (GO:0071625) | 3.25402403 |
| 32 | locomotory exploration behavior (GO:0035641) | 3.22520134 |
| 33 | suckling behavior (GO:0001967) | 3.17226921 |
| 34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.14756961 |
| 35 | postsynaptic membrane organization (GO:0001941) | 3.06431265 |
| 36 | L-fucose catabolic process (GO:0042355) | 3.05507473 |
| 37 | fucose catabolic process (GO:0019317) | 3.05507473 |
| 38 | L-fucose metabolic process (GO:0042354) | 3.05507473 |
| 39 | neurotransmitter transport (GO:0006836) | 3.04344062 |
| 40 | response to auditory stimulus (GO:0010996) | 3.03574437 |
| 41 | regulation of axon guidance (GO:1902667) | 2.99361001 |
| 42 | opioid receptor signaling pathway (GO:0038003) | 2.98234130 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.97538086 |
| 44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.97186779 |
| 45 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.96214554 |
| 46 | glutamate receptor signaling pathway (GO:0007215) | 2.94447095 |
| 47 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.94031396 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.93136961 |
| 49 | regulation of glomerular filtration (GO:0003093) | 2.92948327 |
| 50 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90145270 |
| 51 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.89689837 |
| 52 | axon ensheathment in central nervous system (GO:0032291) | 2.88449183 |
| 53 | central nervous system myelination (GO:0022010) | 2.88449183 |
| 54 | protein localization to synapse (GO:0035418) | 2.88402222 |
| 55 | regulation of neurotransmitter uptake (GO:0051580) | 2.87049596 |
| 56 | ventricular system development (GO:0021591) | 2.86810706 |
| 57 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.85795785 |
| 58 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.85795785 |
| 59 | regulation of membrane repolarization (GO:0060306) | 2.84660482 |
| 60 | dendrite morphogenesis (GO:0048813) | 2.83160044 |
| 61 | sodium ion homeostasis (GO:0055078) | 2.78899529 |
| 62 | cerebellar Purkinje cell layer development (GO:0021680) | 2.77878773 |
| 63 | sodium ion export (GO:0071436) | 2.76519368 |
| 64 | ether lipid metabolic process (GO:0046485) | 2.74627217 |
| 65 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.74465681 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 2.74070586 |
| 67 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.70247617 |
| 68 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.70053465 |
| 69 | oligodendrocyte differentiation (GO:0048709) | 2.69292714 |
| 70 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.67241998 |
| 71 | activation of protein kinase A activity (GO:0034199) | 2.66742360 |
| 72 | positive regulation of protein homooligomerization (GO:0032464) | 2.66210045 |
| 73 | negative regulation of type 2 immune response (GO:0002829) | 2.64964109 |
| 74 | positive regulation of synapse assembly (GO:0051965) | 2.63377751 |
| 75 | regulation of dendritic spine development (GO:0060998) | 2.62928157 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 2.61693252 |
| 77 | neurotransmitter catabolic process (GO:0042135) | 2.59573388 |
| 78 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.59331478 |
| 79 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.59331478 |
| 80 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.58324016 |
| 81 | cellular sodium ion homeostasis (GO:0006883) | 2.56468916 |
| 82 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.56172145 |
| 83 | neuronal action potential propagation (GO:0019227) | 2.55557332 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 2.53377171 |
| 85 | regulation of amino acid transport (GO:0051955) | 2.51363981 |
| 86 | cholesterol catabolic process (GO:0006707) | 2.50616719 |
| 87 | sterol catabolic process (GO:0016127) | 2.50616719 |
| 88 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.50027429 |
| 89 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.49840736 |
| 90 | synaptic vesicle endocytosis (GO:0048488) | 2.49277163 |
| 91 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.49175912 |
| 92 | response to methylmercury (GO:0051597) | 2.48702399 |
| 93 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.48566066 |
| 94 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.44087903 |
| 95 | ATP synthesis coupled proton transport (GO:0015986) | 2.44087903 |
| 96 | auditory behavior (GO:0031223) | 2.43674009 |
| 97 | negative regulation of neurotransmitter transport (GO:0051589) | 2.42959107 |
| 98 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.42939104 |
| 99 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.42628047 |
| 100 | organelle transport along microtubule (GO:0072384) | 2.42451444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.70018425 |
| 2 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.97392962 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92534808 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82889747 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66330342 |
| 6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53705134 |
| 7 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50653518 |
| 8 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.44621231 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41609913 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.36405440 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.36405440 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35643251 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29514763 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20529742 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15949299 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.94951871 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93376802 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92917555 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90079040 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.88821864 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87165535 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.86923992 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86800521 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83466600 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.81412667 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81284704 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77534830 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74788487 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72302992 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70789998 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68510321 |
| 32 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.67341128 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66964817 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66687355 |
| 35 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.59548345 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55922320 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54778028 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53649004 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.53075353 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.49037040 |
| 41 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42002793 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41832684 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39867251 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38530279 |
| 45 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37450923 |
| 46 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.36243853 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33182055 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32719518 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32432593 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30679941 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28746230 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27129705 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25856203 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25740569 |
| 55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.25046290 |
| 56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24076941 |
| 57 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23819375 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22925526 |
| 59 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22097162 |
| 60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19842026 |
| 61 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18939875 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18587162 |
| 63 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16792675 |
| 64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13166493 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11879521 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11521687 |
| 67 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11472340 |
| 68 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11245167 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09240999 |
| 70 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09023341 |
| 71 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06519629 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05837770 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02282567 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02281091 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99937505 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98143559 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97912721 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96277073 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96089380 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95634397 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95634397 |
| 82 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95363581 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94965143 |
| 84 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94713909 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94099508 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93796377 |
| 87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92738051 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91373161 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91096670 |
| 90 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89313835 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89298999 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88369366 |
| 93 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.87956160 |
| 94 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.87837056 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87079762 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86950220 |
| 97 | AR_19668381_ChIP-Seq_PC3_Human | 0.86916350 |
| 98 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85928735 |
| 99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85367813 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85304522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 6.50508977 |
| 2 | MP0005423_abnormal_somatic_nervous | 5.03777623 |
| 3 | MP0004858_abnormal_nervous_system | 3.53877225 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.35111844 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.87052286 |
| 6 | MP0003329_amyloid_beta_deposits | 2.79414330 |
| 7 | MP0002064_seizures | 2.64971172 |
| 8 | MP0004270_analgesia | 2.55204326 |
| 9 | MP0003690_abnormal_glial_cell | 2.54420999 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.52756691 |
| 11 | MP0009745_abnormal_behavioral_response | 2.41079834 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.34249949 |
| 13 | MP0003122_maternal_imprinting | 2.30095007 |
| 14 | MP0001440_abnormal_grooming_behavior | 2.11807577 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.07070935 |
| 16 | MP0009046_muscle_twitch | 2.06170802 |
| 17 | MP0000604_amyloidosis | 2.04570043 |
| 18 | MP0004885_abnormal_endolymph | 2.03128602 |
| 19 | MP0002063_abnormal_learning/memory/cond | 1.97945997 |
| 20 | MP0002822_catalepsy | 1.88780229 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.88565050 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.88059771 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.86482648 |
| 24 | MP0002254_reproductive_system_inflammat | 1.86285157 |
| 25 | MP0001968_abnormal_touch/_nociception | 1.84666962 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.79867911 |
| 27 | MP0001486_abnormal_startle_reflex | 1.79540782 |
| 28 | MP0002272_abnormal_nervous_system | 1.63880770 |
| 29 | MP0005379_endocrine/exocrine_gland_phen | 1.56751044 |
| 30 | MP0005187_abnormal_penis_morphology | 1.56620116 |
| 31 | MP0000920_abnormal_myelination | 1.54845795 |
| 32 | MP0004043_abnormal_pH_regulation | 1.53053449 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52627325 |
| 34 | MP0002736_abnormal_nociception_after | 1.46713577 |
| 35 | MP0005360_urolithiasis | 1.45102279 |
| 36 | MP0005171_absent_coat_pigmentation | 1.43478732 |
| 37 | MP0003634_abnormal_glial_cell | 1.42806049 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.38881685 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.36860651 |
| 40 | MP0005647_abnormal_sex_gland | 1.36611386 |
| 41 | MP0003787_abnormal_imprinting | 1.36124200 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.35214553 |
| 43 | MP0000778_abnormal_nervous_system | 1.33938646 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.33539088 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.30393067 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.29523712 |
| 47 | MP0003633_abnormal_nervous_system | 1.24494423 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.19718351 |
| 49 | MP0004036_abnormal_muscle_relaxation | 1.17777831 |
| 50 | MP0008260_abnormal_autophagy | 1.16204695 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.14817235 |
| 52 | MP0004924_abnormal_behavior | 1.13392516 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.13392516 |
| 54 | MP0003631_nervous_system_phenotype | 1.13087918 |
| 55 | MP0001970_abnormal_pain_threshold | 1.12342908 |
| 56 | MP0002184_abnormal_innervation | 1.11598158 |
| 57 | MP0008995_early_reproductive_senescence | 1.10216269 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.09432430 |
| 59 | MP0003121_genomic_imprinting | 1.08897950 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.08524239 |
| 61 | MP0003632_abnormal_nervous_system | 1.05388552 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.04705084 |
| 63 | MP0002066_abnormal_motor_capabilities/c | 1.02460494 |
| 64 | MP0004142_abnormal_muscle_tone | 1.01502239 |
| 65 | MP0004742_abnormal_vestibular_system | 1.00885990 |
| 66 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97904882 |
| 67 | MP0000955_abnormal_spinal_cord | 0.95275438 |
| 68 | MP0003300_gastrointestinal_ulcer | 0.95196566 |
| 69 | MP0001177_atelectasis | 0.93632837 |
| 70 | MP0002735_abnormal_chemical_nociception | 0.93386044 |
| 71 | MP0003137_abnormal_impulse_conducting | 0.93126319 |
| 72 | MP0010386_abnormal_urinary_bladder | 0.92020422 |
| 73 | MP0003879_abnormal_hair_cell | 0.91351513 |
| 74 | MP0006054_spinal_hemorrhage | 0.90601170 |
| 75 | MP0002882_abnormal_neuron_morphology | 0.90177596 |
| 76 | MP0005646_abnormal_pituitary_gland | 0.85500412 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.85183576 |
| 78 | MP0001664_abnormal_digestion | 0.82390473 |
| 79 | MP0003959_abnormal_lean_body | 0.81614306 |
| 80 | MP0005332_abnormal_amino_acid | 0.78341376 |
| 81 | MP0004811_abnormal_neuron_physiology | 0.78044542 |
| 82 | MP0002229_neurodegeneration | 0.76615244 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.76515289 |
| 84 | MP0005535_abnormal_body_temperature | 0.75195893 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 0.74268346 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.71432748 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.70966486 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.70267568 |
| 89 | MP0001943_abnormal_respiration | 0.67452016 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.66886737 |
| 91 | MP0004085_abnormal_heartbeat | 0.66756728 |
| 92 | MP0003718_maternal_effect | 0.66496844 |
| 93 | MP0002152_abnormal_brain_morphology | 0.65597085 |
| 94 | MP0000751_myopathy | 0.65224911 |
| 95 | MP0002971_abnormal_brown_adipose | 0.63902865 |
| 96 | MP0004130_abnormal_muscle_cell | 0.63353599 |
| 97 | MP0003075_altered_response_to | 0.63133661 |
| 98 | MP0008569_lethality_at_weaning | 0.60404237 |
| 99 | MP0000747_muscle_weakness | 0.58834616 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.57181427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.63899780 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.97173752 |
| 3 | Supranuclear gaze palsy (HP:0000605) | 4.85968535 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 4.25161803 |
| 5 | Polyphagia (HP:0002591) | 4.00181923 |
| 6 | Scanning speech (HP:0002168) | 3.55554277 |
| 7 | Epileptic encephalopathy (HP:0200134) | 3.55247174 |
| 8 | Diplopia (HP:0000651) | 3.52190980 |
| 9 | Abnormality of binocular vision (HP:0011514) | 3.52190980 |
| 10 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.45885760 |
| 11 | Chronic bronchitis (HP:0004469) | 3.41298070 |
| 12 | Spinal cord compression (HP:0002176) | 3.38957026 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 3.28830849 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.28830849 |
| 15 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.27267697 |
| 16 | Delayed CNS myelination (HP:0002188) | 3.18449859 |
| 17 | Status epilepticus (HP:0002133) | 3.14114446 |
| 18 | Agitation (HP:0000713) | 3.07288089 |
| 19 | Myokymia (HP:0002411) | 2.96957319 |
| 20 | Abnormal eating behavior (HP:0100738) | 2.92285920 |
| 21 | Anxiety (HP:0000739) | 2.84052629 |
| 22 | Sensorimotor neuropathy (HP:0007141) | 2.83160123 |
| 23 | Dysmetria (HP:0001310) | 2.82069994 |
| 24 | Focal seizures (HP:0007359) | 2.81595039 |
| 25 | Atonic seizures (HP:0010819) | 2.76188579 |
| 26 | Rhinitis (HP:0012384) | 2.70760433 |
| 27 | Focal motor seizures (HP:0011153) | 2.63783634 |
| 28 | Hemiparesis (HP:0001269) | 2.63106586 |
| 29 | Hyperglycinemia (HP:0002154) | 2.61312658 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 2.60122347 |
| 31 | Abnormal pupillary function (HP:0007686) | 2.60119870 |
| 32 | Truncal ataxia (HP:0002078) | 2.57153700 |
| 33 | Postural instability (HP:0002172) | 2.54629557 |
| 34 | Dysdiadochokinesis (HP:0002075) | 2.53234577 |
| 35 | Febrile seizures (HP:0002373) | 2.48541307 |
| 36 | Psychosis (HP:0000709) | 2.45410669 |
| 37 | Skin nodule (HP:0200036) | 2.43789199 |
| 38 | Excessive salivation (HP:0003781) | 2.42405153 |
| 39 | Drooling (HP:0002307) | 2.42405153 |
| 40 | Nasal speech (HP:0001611) | 2.38597888 |
| 41 | Xanthomatosis (HP:0000991) | 2.36850044 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 2.36507623 |
| 43 | Generalized tonic-clonic seizures (HP:0002069) | 2.34894384 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 2.29636933 |
| 45 | Tachypnea (HP:0002789) | 2.28169707 |
| 46 | Broad metatarsal (HP:0001783) | 2.27200468 |
| 47 | Narrow nasal bridge (HP:0000446) | 2.25305273 |
| 48 | Parakeratosis (HP:0001036) | 2.23138952 |
| 49 | Diastasis recti (HP:0001540) | 2.20377738 |
| 50 | Restlessness (HP:0000711) | 2.20275100 |
| 51 | Spastic paraparesis (HP:0002313) | 2.19128874 |
| 52 | Absence seizures (HP:0002121) | 2.17101606 |
| 53 | Aplasia involving bones of the extremities (HP:0009825) | 2.16856145 |
| 54 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.16856145 |
| 55 | Aplasia of the phalanges of the hand (HP:0009802) | 2.16856145 |
| 56 | Hypophosphatemic rickets (HP:0004912) | 2.14418219 |
| 57 | Spastic gait (HP:0002064) | 2.10948159 |
| 58 | Difficulty running (HP:0009046) | 2.10574588 |
| 59 | Facial shape deformation (HP:0011334) | 2.10170055 |
| 60 | Potter facies (HP:0002009) | 2.10170055 |
| 61 | Amyloidosis (HP:0011034) | 2.08753872 |
| 62 | Urinary urgency (HP:0000012) | 2.07608732 |
| 63 | Prolonged QT interval (HP:0001657) | 2.06832363 |
| 64 | Paraparesis (HP:0002385) | 2.04718715 |
| 65 | Diaphragmatic weakness (HP:0009113) | 2.01435618 |
| 66 | Osteomalacia (HP:0002749) | 2.00707028 |
| 67 | Pheochromocytoma (HP:0002666) | 2.00241403 |
| 68 | Global brain atrophy (HP:0002283) | 1.99810869 |
| 69 | Deep venous thrombosis (HP:0002625) | 1.99136751 |
| 70 | Dialeptic seizures (HP:0011146) | 1.98736521 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 1.98293295 |
| 72 | Tubulointerstitial fibrosis (HP:0005576) | 1.93811538 |
| 73 | Cerebral hemorrhage (HP:0001342) | 1.93472166 |
| 74 | Milia (HP:0001056) | 1.90683535 |
| 75 | Ketosis (HP:0001946) | 1.88354266 |
| 76 | Broad-based gait (HP:0002136) | 1.87933832 |
| 77 | Abnormality of the labia minora (HP:0012880) | 1.82795224 |
| 78 | Chronic otitis media (HP:0000389) | 1.82019655 |
| 79 | Confusion (HP:0001289) | 1.79040124 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 1.78373248 |
| 81 | Cholecystitis (HP:0001082) | 1.78373248 |
| 82 | Retinal dysplasia (HP:0007973) | 1.73377213 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 1.71126939 |
| 84 | Bradykinesia (HP:0002067) | 1.70581294 |
| 85 | Papilledema (HP:0001085) | 1.70210802 |
| 86 | Increased connective tissue (HP:0009025) | 1.70152338 |
| 87 | Split foot (HP:0001839) | 1.68491047 |
| 88 | Neuroendocrine neoplasm (HP:0100634) | 1.67573779 |
| 89 | Hemiplegia (HP:0002301) | 1.65741443 |
| 90 | Abnormality of vision evoked potentials (HP:0000649) | 1.65665027 |
| 91 | Hyperventilation (HP:0002883) | 1.65554917 |
| 92 | Abnormality of macular pigmentation (HP:0008002) | 1.64014744 |
| 93 | Rimmed vacuoles (HP:0003805) | 1.63792835 |
| 94 | Amblyopia (HP:0000646) | 1.63787655 |
| 95 | Prolonged partial thromboplastin time (HP:0003645) | 1.63714336 |
| 96 | Hypoalphalipoproteinemia (HP:0003233) | 1.62893754 |
| 97 | Microretrognathia (HP:0000308) | 1.61125288 |
| 98 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.60943243 |
| 99 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.60943243 |
| 100 | Abnormality of salivation (HP:0100755) | 1.60505878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME1 | 4.42281834 |
| 2 | PAK3 | 3.95122672 |
| 3 | MARK1 | 3.50632399 |
| 4 | PNCK | 2.93553717 |
| 5 | ACVR1B | 2.73721067 |
| 6 | UHMK1 | 2.69087953 |
| 7 | NTRK2 | 2.38929416 |
| 8 | NTRK3 | 2.31241748 |
| 9 | CAMKK2 | 2.25682570 |
| 10 | MAP3K13 | 2.24553131 |
| 11 | PAK6 | 2.18568831 |
| 12 | MAP3K4 | 2.14498058 |
| 13 | CAMKK1 | 1.92697299 |
| 14 | SIK2 | 1.92244216 |
| 15 | PRKD3 | 1.81415390 |
| 16 | ERBB3 | 1.69990215 |
| 17 | EPHA4 | 1.67315232 |
| 18 | CASK | 1.57039315 |
| 19 | MAP2K4 | 1.56886431 |
| 20 | MAP2K7 | 1.56679449 |
| 21 | KSR2 | 1.56078723 |
| 22 | MINK1 | 1.45660821 |
| 23 | CAMK2B | 1.37103245 |
| 24 | CDK5 | 1.37040275 |
| 25 | OXSR1 | 1.32511300 |
| 26 | MAP3K14 | 1.31227144 |
| 27 | PRPF4B | 1.30090592 |
| 28 | MAPK13 | 1.28364063 |
| 29 | BRSK1 | 1.27069045 |
| 30 | PRKCH | 1.21165856 |
| 31 | STK39 | 1.19364387 |
| 32 | BRSK2 | 1.18167339 |
| 33 | LATS2 | 1.15666728 |
| 34 | LIMK1 | 1.13026307 |
| 35 | CAMK2A | 1.10481830 |
| 36 | MST4 | 1.10116404 |
| 37 | CAMK1G | 1.07926500 |
| 38 | NTRK1 | 1.04800041 |
| 39 | PHKG1 | 1.04067518 |
| 40 | PHKG2 | 1.04067518 |
| 41 | FGR | 0.95192465 |
| 42 | BCKDK | 0.95184773 |
| 43 | ROCK2 | 0.94159491 |
| 44 | PRKCG | 0.93823427 |
| 45 | STK24 | 0.93110299 |
| 46 | ADRBK1 | 0.88112383 |
| 47 | SGK1 | 0.86470432 |
| 48 | PKN1 | 0.82345976 |
| 49 | PRKAA2 | 0.79789213 |
| 50 | BMPR1B | 0.79722120 |
| 51 | MAPK12 | 0.78029646 |
| 52 | PRKCE | 0.76091485 |
| 53 | CDK19 | 0.75172534 |
| 54 | SIK1 | 0.73938407 |
| 55 | SGK223 | 0.72574266 |
| 56 | SGK494 | 0.72574266 |
| 57 | PRKCQ | 0.68907831 |
| 58 | CSNK1G2 | 0.68233500 |
| 59 | CAMK2D | 0.67982295 |
| 60 | DAPK2 | 0.67911750 |
| 61 | TTN | 0.66851814 |
| 62 | CAMK2G | 0.66690728 |
| 63 | BCR | 0.62280212 |
| 64 | CSNK1E | 0.62031588 |
| 65 | PASK | 0.61251332 |
| 66 | MAP2K1 | 0.60860351 |
| 67 | FES | 0.59145285 |
| 68 | RPS6KA3 | 0.57382779 |
| 69 | MAP3K9 | 0.55029155 |
| 70 | RET | 0.54386662 |
| 71 | WNK3 | 0.53725598 |
| 72 | PRKACG | 0.53253916 |
| 73 | LRRK2 | 0.52582097 |
| 74 | CAMK1D | 0.52336547 |
| 75 | FYN | 0.50936223 |
| 76 | CDK18 | 0.50295577 |
| 77 | CDK15 | 0.50129117 |
| 78 | SRC | 0.49486971 |
| 79 | CAMK1 | 0.49274107 |
| 80 | FER | 0.48619687 |
| 81 | PRKD1 | 0.47666896 |
| 82 | DYRK2 | 0.46271035 |
| 83 | PRKACB | 0.45701709 |
| 84 | FGFR2 | 0.45110243 |
| 85 | IKBKE | 0.45028097 |
| 86 | KSR1 | 0.44925824 |
| 87 | PTK6 | 0.44667003 |
| 88 | PRKCA | 0.44647667 |
| 89 | CDK14 | 0.43168229 |
| 90 | PRKCB | 0.43058496 |
| 91 | CDK11A | 0.38916164 |
| 92 | CSNK1D | 0.38875933 |
| 93 | PRKACA | 0.38681264 |
| 94 | GRK5 | 0.37748518 |
| 95 | CSNK1G3 | 0.37509580 |
| 96 | GRK6 | 0.37393624 |
| 97 | CSNK1A1L | 0.37224539 |
| 98 | MAPK10 | 0.36626768 |
| 99 | PRKG1 | 0.36413015 |
| 100 | PRKCZ | 0.36058102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.44950517 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.71304535 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.68118749 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.64938272 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.26942039 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.15082938 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.02429448 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92837540 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.92498704 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.89254538 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87844775 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74881197 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72005506 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.66023018 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.58805317 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57059651 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54174742 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53905273 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.53729789 |
| 20 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.53319259 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51095429 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50934719 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49787550 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.44619695 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.34812688 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.34370447 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.29084881 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.25781166 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21811117 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21071255 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20370426 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18989233 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18963022 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16777432 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14421605 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11282161 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.11199981 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.07733562 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.06986403 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05197562 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01495042 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.00103935 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98645086 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93005711 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91395425 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91255552 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90309176 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89912245 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88714333 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88201872 |
| 51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85628315 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83107906 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81073133 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80724116 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79814217 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79478485 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77502837 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76510614 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76448687 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74994811 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74439063 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72683862 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71134644 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69278692 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66326531 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66039247 |
| 67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65951189 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.65940991 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.65630234 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65375688 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65008955 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64313299 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63837196 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62448068 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60824367 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.60252206 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55847058 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55473562 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55289913 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55217145 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54161216 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53391924 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.53017209 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52235315 |
| 85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52161253 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51054791 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50278023 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46954568 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45830087 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45477022 |
| 91 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45157209 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44871862 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42920695 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42660348 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41515526 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39618576 |
| 97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38311149 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37970404 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.37957820 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36882134 |

